MedPath
NMPA Approval

Olaparib Tablets

国药准字HJ20180049

March 20, 2023

H20180049

Drug Information

奥拉帕利片

利普卓

片剂

150mg

化学药品

March 20, 2023

March 19, 2028

Company Information

Applicant Company

ASTRAZENECA AB

SE-151 85 Södertälje, Sweden

Manufacturing Company

abbvie limited; astrazeneca ab

Carretera 2, KM 58.0, Cruce Davila, Barceloneta, PR 00617, Puerto Rico, United States;Gärtunavägen Södertälje, 152 57, Sweden

© Copyright 2025. All Rights Reserved by MedPath